No benefits of albumin supplementation were discerned in the “Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation” (MACHT) [43] or the “Albumin To Prevent Infection in Chronic Liver Failure” (ATTIRE) [44] randomized controlled trials (RCT). This evidence concerns the gene ALB and chronic liver failure.